A science-backed natural supplement that can help you reach your weight loss goals, especially if a GLP-1s is not an option.

Although findings from a large retrospective study supports these positive effects of taking a GLP-1, it’s unclear whether ...

As research suggests the meds don't work as well on those with a strong drive to feed their feelings, we dig into why ...

Preliminary studies suggest GLP-1s may offer long-term protection against the eye disease AMD for people without diabetes.

Ozempic and Wegovy are changing the way we shop. Find out how Thrive Market is helping users find appropriate products with a new, dedicated shopping filter.

The U.S. adult obesity rate, calculated as having a BMI of 30 or higher, has gradually declined to 37% in 2025, dropping from ...

A Gallup poll suggests nearly 8 million fewer people are obese than in 2022 — a drop that coincides with the surging use of ...

GLP-1s hold promise as a potential treatment for alcohol and substance use disorders, according to an expert endocrine ...

The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, ...

GLP-1 receptor agonists show promise in treating various chronic conditions, but potential risks and unanswered questions remain for care of patients with NETs.

Injectable drugs like Wegovy and Zepbound are contributing to a decrease in the U.S. obesity rate, with usage more than doubling in the past year and a half.

The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity ...